Cargando…
Editorial: Adopting drug repurposing to overcome drug resistance in cancer
Autores principales: | Shankar, Eswar, Subramaniam, Vish, Allimuthu, Dharmaraja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175806/ https://www.ncbi.nlm.nih.gov/pubmed/37187616 http://dx.doi.org/10.3389/fcell.2023.1191682 |
Ejemplares similares
-
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022) -
Editorial: Non-genetic adaptive drug resistance in cancer
por: Cerezo, Michaël, et al.
Publicado: (2022) -
Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
por: Li, Lianbo
Publicado: (2022) -
Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
por: Stolfi, Paola, et al.
Publicado: (2020) -
Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction
por: Westmark, Cara J., et al.
Publicado: (2020)